Chris J. van Koppen

3.5k total citations
72 papers, 2.9k citations indexed

About

Chris J. van Koppen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chris J. van Koppen has authored 72 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chris J. van Koppen's work include Receptor Mechanisms and Signaling (34 papers), Estrogen and related hormone effects (14 papers) and Sphingolipid Metabolism and Signaling (11 papers). Chris J. van Koppen is often cited by papers focused on Receptor Mechanisms and Signaling (34 papers), Estrogen and related hormone effects (14 papers) and Sphingolipid Metabolism and Signaling (11 papers). Chris J. van Koppen collaborates with scholars based in Germany, Netherlands and Egypt. Chris J. van Koppen's co-authors include Karl H. Jakobs, Dagmar Meyer zu Heringdorf, Regina Alemany, Neil M. Nathanson, Otto-Erich Brodde, Stefan Dhein, Lutz Pott, Moritz Bünemann, Michael ter Braak and Oliver Vögler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Chris J. van Koppen

72 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris J. van Koppen Germany 31 2.2k 698 593 310 281 72 2.9k
Hitoshi Matsushime Japan 20 2.8k 1.3× 370 0.5× 614 1.0× 315 1.0× 323 1.1× 27 4.6k
John E. Bleasdale United States 25 1.8k 0.8× 612 0.9× 260 0.4× 236 0.8× 641 2.3× 56 3.7k
Nicole Defer France 30 2.2k 1.0× 710 1.0× 196 0.3× 207 0.7× 360 1.3× 81 3.1k
Kid Törnquist Finland 30 1.7k 0.8× 355 0.5× 475 0.8× 180 0.6× 314 1.1× 143 2.5k
Kristin A. Anderson United States 28 3.1k 1.4× 528 0.8× 272 0.5× 291 0.9× 707 2.5× 36 4.1k
H. Streb Germany 7 1.8k 0.8× 650 0.9× 563 0.9× 173 0.6× 323 1.1× 9 2.7k
I. Schulz Germany 6 1.7k 0.8× 608 0.9× 527 0.9× 181 0.6× 312 1.1× 7 2.6k
C C Malbon United States 39 3.1k 1.5× 1.2k 1.8× 343 0.6× 544 1.8× 1.1k 3.8× 81 4.5k
Lucı́a Núñez Spain 33 1.5k 0.7× 680 1.0× 228 0.4× 198 0.6× 592 2.1× 86 3.0k
Patricia McDonald United States 23 2.7k 1.3× 1.2k 1.8× 356 0.6× 183 0.6× 226 0.8× 52 3.4k

Countries citing papers authored by Chris J. van Koppen

Since Specialization
Citations

This map shows the geographic impact of Chris J. van Koppen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris J. van Koppen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris J. van Koppen more than expected).

Fields of papers citing papers by Chris J. van Koppen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris J. van Koppen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris J. van Koppen. The network helps show where Chris J. van Koppen may publish in the future.

Co-authorship network of co-authors of Chris J. van Koppen

This figure shows the co-authorship network connecting the top 25 collaborators of Chris J. van Koppen. A scholar is included among the top collaborators of Chris J. van Koppen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris J. van Koppen. Chris J. van Koppen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelsamie, Ahmed S., Giuseppe Felice Mangiatordi, Paweł P. Jagodzińśki, et al.. (2021). 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer. ACS Medicinal Chemistry Letters. 12(12). 1920–1924. 5 indexed citations
2.
Müller, Sebastian, Ahmed S. Abdelsamie, Chris J. van Koppen, et al.. (2019). Effects of 17β-HSD2 inhibition in bones on osteoporosis based on an animal rat model. The Journal of Steroid Biochemistry and Molecular Biology. 192. 105405–105405. 6 indexed citations
3.
Koppen, Chris J. van, Qingzhong Hu, Cláudia Scheuer, et al.. (2017). Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing’s Disease. Journal of Medicinal Chemistry. 60(12). 5086–5098. 24 indexed citations
4.
Koppen, Chris J. van & Rolf W. Hartmann. (2015). Advances in the treatment of chronic wounds: a patent review. Expert Opinion on Therapeutic Patents. 25(8). 931–937. 52 indexed citations
5.
Koppen, Chris J. van, Olga V. Surovtseva, Marcel E. de Gooyer, et al.. (2012). Complete Inhibition of rhTSH-, Graves' Disease IgG-, and M22-Induced cAMP Production in Differentiated Orbital Fibroblasts by a Low-Molecular-Weight TSHR Antagonist. The Journal of Clinical Endocrinology & Metabolism. 97(5). E781–E785. 31 indexed citations
6.
7.
Bonger, Kimberly M., Gijsbert M. Grotenbreg, Chris J. van Koppen, et al.. (2010). Oligoproline helices as structurally defined scaffolds for oligomeric G protein-coupled receptor ligands. Organic & Biomolecular Chemistry. 8(8). 1881–1881. 22 indexed citations
8.
Bonger, Kimberly M., Sascha Hoogendoorn, Chris J. van Koppen, et al.. (2009). Synthesis and Pharmacological Evaluation of Dimeric Follicle‐Stimulating Hormone Receptor Antagonists. ChemMedChem. 4(12). 2098–2102. 16 indexed citations
9.
Lee, Miranda M.C. van der, Marion Blomenröhr, Jesse W.Y. Wat, et al.. (2009). Pharmacological Characterization of Receptor Redistribution and β-Arrestin Recruitment Assays for the Cannabinoid Receptor 1. SLAS DISCOVERY. 14(7). 811–823. 37 indexed citations
10.
Bonger, Kimberly M., Richard J. B. H. N. van den Berg, Laura H. Heitman, et al.. (2009). Discovery of Selective Luteinizing Hormone Receptor Agonists Using the Bivalent Ligand Method. ChemMedChem. 4(7). 1189–1195. 10 indexed citations
11.
Koppen, Chris J. van & Karl H. Jakobs. (2004). Arrestin-Independent Internalization of G Protein-Coupled Receptors. Molecular Pharmacology. 66(3). 365–367. 52 indexed citations
12.
13.
Alemany, Regina, Dagmar Meyer zu Heringdorf, Chris J. van Koppen, & Karl H. Jakobs. (1999). Formyl Peptide Receptor Signaling in HL-60 Cells through Sphingosine Kinase. Journal of Biological Chemistry. 274(7). 3994–3999. 89 indexed citations
14.
Vögler, Oliver, et al.. (1999). RhoA-Sensitive Trafficking of Muscarinic Acetylcholine Receptors. Journal of Pharmacology and Experimental Therapeutics. 288(1). 36–42. 23 indexed citations
15.
Schmidt, Martina, et al.. (1995). Rapid and Persistent Desensitization of m3 Muscarinic Acetylcholine Receptor-stimulated Phospholipase D. Journal of Biological Chemistry. 270(34). 19949–19956. 39 indexed citations
16.
Koppen, Chris J. van, et al.. (1994). Deletion analysis of the m4 muscarinic acetylcholine receptor. European Journal of Biochemistry. 222(2). 525–531. 35 indexed citations
17.
Koppen, Chris J. van, W. Lenz, & Neil M. Nathanson. (1993). Isolation, sequence and functional expression of the mouse m4 muscarinic acetylcholine receptor gene. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1173(3). 342–344. 11 indexed citations
18.
Koppen, Chris J. van & Neil M. Nathanson. (1991). The Cysteine Residue in the Carboxyl‐Terminal Domain of the m2 Muscarinic Acetylcholine Receptor Is Not Required for Receptor‐Mediated Inhibition of Adenylate Cyclase. Journal of Neurochemistry. 57(6). 1873–1877. 24 indexed citations
19.
Koppen, Chris J. van, et al.. (1989). Muscarinic receptor binding in central airway musculature in chronic airflow obstruction. Pulmonary Pharmacology. 2(3). 131–136. 5 indexed citations
20.
Koppen, Chris J. van & Mordechai Sokolovsky. (1988). Evidence for an endogenous factor involved in maintenance of pirenzepine high-affinity binding in rat brain stem. Biochemical and Biophysical Research Communications. 157(1). 42–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Matsushime Breakdown of academic impact, for papers by John E. Bleasdale Breakdown of academic impact, for papers by Nicole Defer Breakdown of academic impact, for papers by Kid Törnquist Breakdown of academic impact, for papers by Kristin A. Anderson Breakdown of academic impact, for papers by H. Streb Breakdown of academic impact, for papers by I. Schulz Breakdown of academic impact, for papers by C C Malbon Breakdown of academic impact, for papers by Lucı́a Núñez Breakdown of academic impact, for papers by Patricia McDonald
Rankless by CCL
2026